2019
DOI: 10.1016/j.scitotenv.2019.134011
|View full text |Cite
|
Sign up to set email alerts
|

Implementing standardized desorption extraction into bioavailability-oriented bioremediation of PAH-polluted soils

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 26 publications
(10 citation statements)
references
References 22 publications
0
7
1
Order By: Relevance
“…A similar pattern was observed after chemical oxidation. The results presented in this paper are also in contradiction with the theory exposed by Posada-Baquero et al [40], even though the reported phytoremediation results are based on different plants. In the present paper, the PAHs' bioaccessible contents throughout the rhizoremediation trial show almost similar patterns for (un)planted soil samples (Figures 3b, 4b, 5b and 6b).…”
Section: Reference Tested Plant (S) Phytoremediation Conditions Phytoremediation Outcomescontrasting
confidence: 99%
See 1 more Smart Citation
“…A similar pattern was observed after chemical oxidation. The results presented in this paper are also in contradiction with the theory exposed by Posada-Baquero et al [40], even though the reported phytoremediation results are based on different plants. In the present paper, the PAHs' bioaccessible contents throughout the rhizoremediation trial show almost similar patterns for (un)planted soil samples (Figures 3b, 4b, 5b and 6b).…”
Section: Reference Tested Plant (S) Phytoremediation Conditions Phytoremediation Outcomescontrasting
confidence: 99%
“…The bioaccessible PAHs' contents, however, show contrasting patterns. Posada-Baquero et al [40,41] reported that, generally speaking, techniques such as phytoremediation or biostimulation seem to lead to decreases in PAHs bioaccessible contents, whilst techniques that were more focused on influencing bioaccessibility, such as the addition of surfactants or bioaugmentation, seem to lead to increases in the PAHs' bioaccessible contents. However, the results reported by Medina et al [42] also showed an increase in PAHs bioaccessible contents after biostimulation was employed.…”
Section: Reference Tested Plant (S) Phytoremediation Conditions Phytoremediation Outcomesmentioning
confidence: 99%
“…Recently, studies have started to assess the bioavailability of PAHs in soils/sediments after undergoing remediation. Posada-Baquero et al (2019 recently applied the ISO/TS 16751 norm to determine the environmental availability of PAHs in aged-contaminated soils before and after remediation treatments, and our team measured PAH bioaccessibility throughout a bioremediation trial (Davin et al, 2019) and a rhizoremediation trial (Davin et al, 2020) before the norm came out.…”
Section: On the Use Of The Bioaccessibility Parameter In Remediation mentioning
confidence: 99%
“…Other groups of compounds that have often not been studied are the transformation products (TPs) of parent PAHs (PAH-TPs), such as hydroxylated PAHs (OHPAHs), and other PACs, such as sulfur heterocyclic PAHs (PASHs) and oxygen heterocyclic PAHs (PAOHs). ,, Screening PAH-TPs and other PACs is important not only because it will result in better representation of the actual profile of PAC-contaminated soil sites but also because some of these compounds are known to be toxic and/or mutagenic. Recent studies of the remediation of PAC-contaminated soils showed the association between an increase in toxicity or genotoxicity and an increase in the concentrations of PAH-TPs and PAC. ,, Another important aspect in remediation of PAC-contaminated soil sites that was also typically not assessed was the bioavailability of fractions of the soil post-remediation. Some studies have shown that bioavailability of PAC increased post-remediation, which is relevant to measure because of the potential environmental health implications for organisms in the terrestrial ecosystem. The chemical, toxicity, and bioavailability assessments are needed to address the knowledge gap regarding the presence, properties, and toxicity of PAH-TPs and other PACs.…”
Section: Introductionmentioning
confidence: 99%